The RyR1 antibody is a highly specific immunological tool designed to target the Ryanodine Receptor 1 (RyR1), a calcium channel critical for excitation-contraction coupling in skeletal muscle. RyR1 is a ~560 kDa transmembrane protein localized to the sarcoplasmic reticulum, playing a central role in releasing calcium ions during muscle contraction . The antibody is commonly used in research and diagnostics to study muscle physiology, neuromuscular disorders, and immune system interactions .
Epitope: Targets the N-terminal intracellular region, specifically residues 1371–1386 of human RyR1 .
Host Species: Produced in rabbit (polyclonal) or mouse (monoclonal) systems .
Applications: Validated for Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF), and immunocytochemistry (ICC) .
RyR1 forms a large ion channel complex with three B30.2/SPRY domains and five MIR domains, enabling calcium release from the sarcoplasmic reticulum . Its dysfunction is linked to:
Malignant Hyperthermia (MH): Dominant mutations in RYR1 disrupt calcium regulation, causing lethal hypermetabolic crises during anesthesia .
Central Core Disease: Congenital myopathy characterized by abnormal muscle fibers and impaired calcium signaling .
The antibody is instrumental in studying:
RyR1 antibodies are critical in:
Genetic Testing: Identifying RYR1 mutations linked to MH and myopathies .
Therapeutic Monitoring: Tracking calcium channel dynamics in neuromuscular therapies .
Immune System Activation: Gain-of-function RYR1 mutations enhance dendritic cell maturation and antibody production, suggesting therapeutic potential for vaccines .
Muscle Physiology: RyR1-null models reveal calcium-dependent muscle fragility and altered membrane integrity .
Cancer Biology: RyR1 modulates calcium signaling in tumor-associated macrophages, influencing metastasis .
KEGG: spo:SPAC4C5.02c
STRING: 4896.SPAC4C5.02c.1